Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cardiomyocytes are shielded from chemotherapy damage by mitochondrial proteins.

2.

Which Risk Model Better Identifies High-Risk Smoldering MM?

3.

Cancer and HIV Vaccines Enter the Therapeutic Era

4.

COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment

5.

Coffee, Tea Tied to Lower Risk of Head and Neck Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot